ALKS

#1132
Alkermes Inc. plc
30.10
-1.89%
부문:
베이스:
수익 통화:
일일 변동 비율
30.10
30.10
년간 변동
25.16
36.32
일일 변동
-1.89%
월간 변동
-11.26%
6달 변화
+3.33%
년간 변동율
-12.09%
이전 종가
30.68
Open
30.10
Bid
Ask
Low
30.10
High
30.10
양
150
Open full chart

Financials

Overview 성명 Statistics Dividends
Quarterly Annual
  • Market Capitalization 4.96 B
  • Employee 1 800
  • Founded 1987
  • CEO Richard F. PopsRichard F. Pops
  • Website www.alkermes.com
  • Headquarter Ireland
  • FIGI UNKNOWN
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
19.57
Price to sales ratio
3.2
Dividends per share
—
Dividend yield %
—

Alkermes plc

Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall. In September 2011 Alkermes, Inc. merged with Elan Drug Technologies, the former drug formulation and manufacturing division of Élan Corporation, plc. The company is headquartered in Dublin, and has an R&D center in Waltham, Massachusetts, and a manufacturing facility in Wilmington, Ohio.

뉴스